 |
愳熀岶堦尋媶幒
仹113-8549
搶嫗搒暥嫗嬫搾搰1-5-45
堛帟妛憤崌尋媶搹乮嘦婜搹乯 6奒
TEL 03-5803-5931
|
 |
|
儊乕儖偱偺偍栤偄崌傢偣
 |
|
|
 |
媽僔儔僶僗
丂syllabus
|
 |
|
堛椕宱嵪妛偺偨傔偺儈僋儘宱嵪妛擖栧
--- Intermediate Microeconomics for Health Care Economics
---
|
 |
扴摉幰丗
|
|
 |
彫椦 峲(旕忢嬑島巘)
|
|
島媊擔掱丗
|
|
|
2006擭5寧乣9寧(慡16夞傪梊掕)丄栘梛18:00乣20:00
|
|
島媊偺栚昗丗
|
|
|
偙偺島媊偱偼丄堛椕宱嵪妛傊偺墳梡傪擮摢偵抲偒側偑傜儈僋儘宱嵪妛偺婎慴棟榑傪妛傇丅摿偵儈僋儘宱嵪妛偺峫偊曽傪懱宯揑偵棟夝偡傞偲偲傕偵丄僌儔僼傗悢幃傪拞怱偲偟偨條乆側暘愅摴嬶偺巊偄曽傪廗摼偡傞偙偲傪栚巜偡丅 |
|
島媊寁夋(巄掕斉)丗
|
|
|
戞1夞 廀梫偲嫙媼丗廀梫嬋慄丒嫙媼嬋慄丒巗応嬒峵丒壙奿抏椡惈
戞2夞
惗嶻幰棟榑1丗棙弫嵟戝壔栤戣丒惗嶻娭悢偲旓梡娭悢丒嵿嫙媼偲梫慺廀梫
戞3夞
惗嶻幰棟榑2丗惗嶻梫慺慖戰丒旓梡嵟彫壔栤戣丒惗嶻壜擻惈僼儘儞僥傿傾
戞4夞 徚旓幰棟榑1丗岠梡娭悢偲柍嵎暿嬋慄丒梊嶼惂栺丒戙懼岠壥偲強摼岠壥
戞5夞
徚旓幰棟榑2丗岠梡嵟戝壔偲巟弌嵟彫壔丒曗彏廀梫丒僗儖僣僉乕暘夝
戞6夞 楯摥嫙媼丗楯摥偲梋壣丒楯摥嫙媼娭悢丒棷曐捓嬥
戞7夞
挋拁丗徚旓偲挋拁丒儔僀僼僒僀僋儖壖愢丒棳摦惈惂栺
戞8夞 堦斒嬒峵暘愅丗僷儗乕僩嵟揔丒嫞憟嬒峵丒岤惗宱嵪妛偺婎杮掕棟
戞9夞
晹暘嬒峵暘愅丗徚旓幰梋忚丒惗嶻幰梋忚丒僷儗乕僩尨棟偲曗彏尨棟
戞10夞 壽惻偺岤惗暘愅丗壽惻偺挻夁晧扴丒惻晧扴偺揮壟丒嵟揔壽惻榑
戞11夞
晄姰慡嫞憟丗撈愯婇嬈偺峴摦丒撈愯偺岤惗懝幐丒帺慠撈愯偲壙奿婯惂
戞12夞 奜晹惈丗奜晹惈偺岤惗懝幐丒僺僌乕揑夝寛朄丒僐乕僗偺掕棟
戞13夞
岞嫟嵿丗弮悎岞嫟嵿偺惈幙丒僒儈儏僄儖僜儞忦審丒僼儕乕儔僀僟乕栤戣
戞14夞 晄妋幚惈丗婜懸岠梡棟榑丒曐尟偺婡擻丒曐尟偲擭嬥
戞15夞
僎乕儉棟榑丗僫僢僔儏嬒峵丒僋乕儖僲乕嫞憟丒孞傝曉偟僎乕儉
戞16夞
晄姰旛忣曬丗僄乕僕僃儞僔乕棟榑丒儌儔儖僴僓乕僪丒媡慖戰
|
|
悢妛偵偮偄偰丗
|
|
|
埲壓偺奣擮偵帺怣偑側偄幰偼帠慜偵曌嫮偟偰偍偔偙偲丅
亙娭悢丄楢棫曽掱幃丄巜悢丒懳悢丄旝暘(曃旝暘丒慡旝暘丒崌惉旝暘)丄愊暘亜
|
|
惉愌昡壙丗
|
|
|
枅夞島媊偺朻摢10暘傎偳偱彫僥僗僩傪峴偄丄偦偺憤崌摼揰偱昡壙偡傞丅島媊偵寚惾丒抶崗傪偡傞偲彫僥僗僩傪庴偗傞偙偲偑偱偒側偄偺偱拲堄偝傟偨偄丅
|
|
嶲峫暥專丗
|
|
|
幗攷梇[曇]亀堛椕宱嵪妛亁搶嫗戝妛弌斉夛.
愳熀岶堦亀堛椕夵妚丗捝傒傪姶偠側偄惂搙愝寁傪亁搶梞宱嵪怴曬幮.
晲孏怲堦亀儈僋儘宱嵪妛亁怴悽幮.
堜杧棙岹亀擖栧儈僋儘宱嵪妛亁怴悽幮.
Folland,
S. et al. The Economics of Health and Health Care, Prentice Hall.
Mas-Colell,
A. et al. Microeconomic Theory, Oxford University Press.
Varian, H.
Intermediate Microeconomics,
Norton. |
|
|
|
Tokyo Medical
and Dental University
Division of Public Health
Health Care Economics
Program
|
Thursday 18:00-20:00
Professor : Koichi Kawabuchi
1-5-45
Yushima Bunkyo-ku Tokyo 113-8549 ,Japan
kawabuchi.hce@tmd.ac.jp
Tel
+81-03-5803-5931
Fax
+81-03-5803-5933
|
2005擭搙丂Course Syllabus乮僐乕僗僔儔僶僗乯
|
Goal
|
|
|
This course uses the tools of microeconomics and empirical
analysis to study health care delivery system with collaboration of donation
program on health Care management which has started in Sep.2003. The principal
goal is to become proficient in evaluating empirical analyses and in applying
economics reasoning to health-related issues. In particular, the course focuses
on how payment systems, government policies and industrial organization affect
the incentives and environment for particular agents and institutions within and
beyond the health sector.
And also the courses in heath care policy are
designed to complement the conceptual framework provided by the business core.
Their purposes is to prepare the graduate for high-level professional practice
in the industry by emphasizing the application of principle from the business
disciplines.
|
|
Class Preparation and
Participation
|
|
|
The Course requirements include written exercises due in five
of the 10 weeks of the semester, an oral presentation in a discussion group,
attendance at and critique of at least one Workshop in Health Care Management,
and a final examination. The written exercises are one to three-page responses
to questions on reading and lecture material. The oral presentations, are ten to
fifteen minutes on a subject in the course of particular interest to the
student. The workshop critiques of three or four pages are based on
presentations each week by faculty, staff, and Ph.D. candidates from the
University as well as researchers from other universities and health
organizations on their current work concerning the health status of the
population and the organization and delivery of health care.
In most week,
study questions will be provided to facilitate understanding of the course
material. These will include technical problems which should be completed during
the week and solutions will be reviewed the following week. Although these are
not graded, they are extremely good practice for the examinations.
Student
participation and discussion is expected. All students should come to each class
prepared to discuss issues raised in the assigned readings or to explain their
solutions to assigned problems to the best of their
ability.
|
|
The
commitment
|
|
|
This is an intermediate economics course at the graduate level.
To successfully learn the material, students should be prepared to devote at
least eight hours a week to the course, exclusive of class
time.
|
|
Grades
|
|
|
Course grades will be calculated as follows:
Short essays
and written exercises to be turned in before each class 35(7亊5)%
Class
Participation 5%
Oral presentation 20%
Workshop critique 10%
Final
Examination Either July 3 or Dec 4 30%
|
|
|
Textbook and reading
Packet
愳熀岶堦挊乽堛椕夵妚乣捝傒傪姶偠側偄惂搙愝寁傪乿乮搶梞宱嵪怴曬幮乯
愳熀岶堦挊乽恑壔偡傞昦堾儅僱僕儊儞僩乣堛椕偲宱塩偺幙偑傢偐傞恖嵽堢惉傪栚巜偟偰乿乮堛妛彂堾乯
仸
Reading packet: A reading packet with most of the other readings is available
for the original in our office.
|
|
Downloadable
Readings
|
|
|
Many of the readings are available free on the internet.
Locations are marked below.
Please note:
|
|
1.
|
Government Site |
|
|
http://www.fedworld.gov/
http://www.hud.gov/index.html
http://thomas.log.gov/
http://www.census.gov/
http://www.gpo.gov/
http://www.bls.gov/
http://www.acf.dhhs.gov/
http://www.dhhs.gov/
|
|
2.
|
Organization sites
|
|
|
http://www.ncsl.org/
http://www.apha.org/
http://www.cwla.org/
http://qsilver.queensu.ca/appam/
http://www.aspanet.org/
http://www.cato.org/
http://www.philanthropy.com/
http://www.icpsr.umich.edu/
http://www.aphsa.org/
http://www.povertylaw.org/
http://www.citylimits.org/
http://gwbweb.wustl.edu/websites.html
http://www.napawash.org/
http://www.brookings.org/
http://www.cgr.org/
http://www.andromeda.rutgers.edu/~ncpp.html
http://www.rand.org/
|
|
|
Downloads from JSTOR, NBER and some of the journal websites can
only be obtained through a connection from NYU or another subscribing
institution; they cannot be accessed from commercial internet service
providers.
The New York Times website requires (free) registration for
access.
The New England Journal of Medicine website requires log
in.
Please note that this is a preliminary schedule. Updates will be
announced in class.
|
|
|
戞1夞丂5寧19擔
|
|
|
亂敪昞幰亃乮榑暥挊幰柤徣棯乯仸敪昞50暘丄摙榑亖10暘/恖
|
|
(1)
|
棲渳乮Liu Yi乯
|
|
戞2夞丂6寧16擔
|
|
(2)
|
栃奐乮Meng Kai乯
|
|
* |
Should We Be Worried About High Real Medical Spending Growth In
The United States?: Health Affairs
|
|
* |
Improvement in maternal health literacy among pregnant women
who did not complete compulsory education:policy implications for community care
services:Health Policy
|
|
* |
China's evolving health care market:how doctors feel and what
they think:Health Policy
|
|
(3)
|
捖攼掛
|
|
* |
Evaluating the comparability of different grouping schemes for
mortality and morbidity:Health Policy
|
|
* |
Association of hospital ownership with patient transfers to
outpatient care under a prospective system in Taiwan:Health
Policy
|
|
* |
Effects of Global Budgeting on the Distribution of Dentists and
Use of Dental Care in Taiwan:Health Services Research
|
|
* |
National Lessons in Financing of Health Care:Cost Convergence
between Public and For-Profit Hospitals under Prospective Payment and High
Competition in Taiwan: Health Services Research
|
|
戞3夞丂6寧23擔
|
|
(4)
|
幱峠
|
|
* |
Medical savings accounts in a universal system:wishful thinking
meets evidence:Health Policy
|
|
* |
Estimation of the impact of providing outpatients with
information about SARS infection control on their infection of outpatient
visit:Health Policy
|
|
* |
Rethinking the Cesarean Rate:How Pregnancy Complications May
Affect Interhospital Comparisons:Medical Care
|
|
(5)
|
僐僂僔儏
|
|
* |
Depression 20 Years of Progress:Medical
Care
|
|
* |
Chronic Medical Illness,Depressin,and Use of Acute Medical
Service Among Medicare Beneficiaries: Medical Care
|
|
* |
Older Patients with Serious Mental Illness:Sensitivity to
Distance Barriers for Outpatient Care:Medical Care
|
|
* |
Escalating Health Care Spending:Is It Desirable Or
Inevitable:Health Affairs
|
|
戞4夞丂7寧7擔
|
|
(6)
|
栘懞寷梞
|
|
* |
Validity of Procedure Codes in International Classification of
Diseases,9th revision,Clinical Modification Administrative Data:Medical
Care
|
|
* |
Choosing to Convert to Critical Access Hospital Status:Health
Care Financing Review
|
|
* |
Computerized Knowledge Management in Diabetes Care:Medical
Care
|
|
(7)
|
暉壀懢塸巕
|
|
* |
The Role of Pharmacoepidemiology and Pharmacoeconomics in
Promoting Access and Stimulating
Innovation:Pharmacoeconomics
|
|
* |
The Effects of Pharmaceutical Consumption and Obesity on the
Quality of Life in the Organization of Economic Cooperation and Development
(OECD)丂Countries: Pharmacoeconomics
|
|
* |
Education in Pharmacoeconomics:An International
Multidisciplinary View:Phamacoeconomics
|
|
戞5夞丂7寧14擔
|
|
(8)
|
屻摗杚恖
|
|
* |
Impacts of Informal Caregiver Availability on Long-term Care
Expenditures in OECD Countries:Health Services Research
|
|
* |
The Disparity in Access to New Medication by Type of Health
Insurance:Lessons From Germany:Medical Care
|
|
* |
Access to physician services:does suppulemental insurance
matter? Evidence from France:Health Economics
|
|
(9)
|
暉壀桋夘 |
|
* |
Teamwork Culture and Patient Satisfaction in Hospitals:Medical
Care
|
|
* |
Association of hospital resource use with comorbidity status
and patient age among hip fracture patients in Japan:Health
Policy
|
|
* |
Challenges in Measuring Nursing Home and Home Health
Quality:Lessons From the First National Healthcare Quality Report:Medical
Care
|
|
戞6夞丂7寧21擔
|
|
(10)
|
Tewarit
|
|
* |
Shifting the burden of health care finance:a case study of
public-private partnership in Singapore:Health Policy
|
|
* |
Capacity in Thai Public Hospitals and the Production of Care
for Poor and Nonpoor Patients: Health Services Research
|
|
* |
The private demand for an AIDS vaccine in Thailand:Health
Policy
|
|
(11)
|
Direk
|
|
* |
Comparing alternative models:log vs Cox proportional
hazard?:Health Economics
|
|
* |
Quality Improvement Efforts and Hospital Performance:Rate of
Beta-Blocker Prescription After Acute Myocardial Infarction:Medical
Care
|
|
* |
Hospital-Level Racial Disparities in Acute Myocardial Infaction
Treatment and Outcomes:Medical Care
|
|
戞7夞丂7寧28擔
|
|
(12)
|
姳曐塰乮Yu乯
|
|
* |
Hospital-Level Performance Improvement Beta-Blocker Use After
Acute Myocardial Infarction:Medical Care
|
|
* |
Describing Chinese hospital activity with diagnosis related
groups(DRGs):A case study in Chengdu:Health Policy
|
|
* |
An Economic Evaluation of Fluvastatin used for the Prevention
of Cardiac Events Following Successful First Percutaneous Coronary Intervention
in the UK:Pharmacoeconomics
|
|
(13)
|
棲愰廏
|
|
* |
Diagnosis and treatment of pulmonary tuberculosis at basic
health care facilities in rural Vietnam:a survey of knowledge and reported
practices among health staff:Health Policy
|
|
|
Perceptions and experiences of health care seeking and access
to TB care-a qualitative study in Rural Jiangsu Province,China:Health
Policy
|
|
* |
Racial Inequities in the Timing of Breast Cancer
Detection,Diagnosis,and Initiation of Treatment:Medical
Care
|
|
戞8夞丂9寧1擔
|
|
(14)
|
媑堜弐擇
|
|
* |
Mortality After Cardiac Bypass Surgery:Prediction From
Administrative Versus Clinical Data:Medical Care
|
|
* |
Mortality After Noncardiac Surgery:Prediction From
Administrative Versus Clinical Data:Medical Care
|
|
* |
International differences in the impact of doctors on health:a
multilevel analysis of OECD countries:Journal of Health
Economics
|
|
(15)
|
愇
|
|
* |
Are Damages Caps Regressive?:A Study Of Malpractice July
Verdicts In California:Health Affairs
|
|
* |
National Health Insurance:Falling Expectations and the Safety
Net:Medical care
|
|
* |
Recent Trends and Geographic Variation in the Safety
Net:Medical care
|
|
* |
Racial,Ethnic,and Scocioeconomic Disparities in Estimates of
AHRQ Patient Safety Indicators:Medical Care
|
|
戞9夞丂9寧8擔
|
|
(16)
|
惣揷
|
|
* |
Net Health Plan Savings From Reference Pricing for
Angiotensin-Converting Enzyme Inhibitors in Elderly British Columbia
Residents:Medical Care
|
|
* |
The Health Effects of Restricting Prescription Medication Use
Because of Cost:Medical Care
|
|
* |
The Economics of Follow-on Drug Research and
Development:Pharmacoeconomics
|
|
(17)
|
媑栴
|
|
* |
Clinical Management Strategies and Diabetes Quality:What Can We
Learn from Observational Studies?:Medical Care
|
|
* |
The Influence of Physicians' Practice Management Strategies and
Financial Arrangements on Quality of Care Among Patients With Diabetes:Medical
Care
|
|
* |
The Role of Perceived Team Effectiveness in Improving Chronic
Illness Care:Medical Care
|
|
戞10
夞丂9寧15擔
|
|
(18)
|
庰姫
|
|
* |
Trends in Nursing Home Expenses,1987 and 1996:Health Care
Financing Review
|
|
* |
Access To Conventional Medical Care And The Use Of
Complementary And Alternative Medicine:Health Affairs
|
|
(19)
|
婫
|
|
* |
Is Case-Mix Adjustment Necessary for an Expanded Dialysis
Bundle?: Health Care Financing Review
|
|
* |
Physician Process and Patient Outcome Measures for Diabetes
Care:Relationships to Organizational Characteristics:Medical
Care
|
|
* |
Why Do People Report Better Health by Phone Than by
Mail?:Medical Care
|
|
仸12寧丗撽揷榓枮愭惗丄堜埳夒巕愭惗偺摑寁妛偺廤拞島媊乮俁夞梊掕乯傪梊掕丅
仸暯惉15擭9寧偐傜偼堛椕宱塩愱栧怑戝妛堾愝抲偵岦偗偨婑晬島嵗傪奐島丅
|
|
|
|
仛
|
Final Examination
Economics
Record Examination
宱嵪妛専掕帋尡乮庡嵜丗擔杮宱嵪妛嫵堢嫤夛乯
http://vivid-keizai.khk.co.jp
|
|
仸Reference: A reading packet
which was used in 2004's program
|
| 丂 |
* |
Cardiac procedure Use and Outcomes in Elderly Patients with
Acute myocardial Infarction in the United States and Quebec, Canada, 1988 to
1994, Medical Care, Vol.41, No7,pp813-822.
|
|
* |
In-Hospital Mortality Following Coronary Artery Bypass Graft
Surgery in Veterans Health Administration and Private Sector Hospitals,丂Medical
Care,Vol41,No.4,pp522-535.
|
|
* |
Comparing systems for costing hospital treatments-The case of
stable angina pectoris, Health Policy, 67(2004)293-307).
|
|
* |
Reductions in Individual Work Productivity Associated with
Type2 Diabetes Mellitus, Phamacoeconomics,
2003:21(15):1123-1134.
|
|
* |
Racial Disparities in Diabetes Care Processes, Outcomes, and
Treatment Intensity, MedicalCare, Vol41,No.11,pp1211-1232.
|
|
* |
Changing health in China: Re-evaluating the epidemiological
transition model,Health Policy67(2004)329-343.
|
|
* |
Tooth retention as an Indicator of Quality Dental Care:
Development of Risk Adjustment Model, Medical
Care,vol.41,No.8,pp937-949.
|
|
* |
Racial Variations in Dental Procedures :The Case of Root Canal
Therapy versus Tooth Extraction, Medical
Care,vol41,No.11,pp1256-1261.
|
|
* |
The changing public/private mix in dentistry in the UK-a supply
-side perspective, Health Economics,12:309-321(2003).
|
|
* |
The effects of payment method on clinical
Decision-making,Health Medical Care,Vol.42,No3,2004.
|
|
* |
National health insurance and the antenatal care use: a case in
Taiwan,Health Policy,64(2003)99-112.
|
|
* |
Taiwan's New National Health Insurance Program: Genesis and
Experience So Far, Health Affairs, Vol.22,No.3.
|
|
* |
Provider Perceptions of pharmacy Management -Lesson From the
Military Health System, Medical Care,Vol.42, No.4,April
2004.
|
|
* |
A Pharmaeconomic Review of its use in Percutaneous Coronary
Intervention and Acute Coronary Syndromes,
PhamacoEconomics2003:21(12):885-912.
|
|
* |
Do Well-Publicized Risk-Adjusted Ourcomes reports Affect
Hospital Volume?, Medical Care,Vol42,No.4,April 2004.
|
|
* |
Nurse staffing and mortality for medicare patients with acute
myocardial infarction, Medical Care, Vol42,No.1,2004.
|
|
* |
Does publicizing Hospital performance Stimulate Quality
Improvement Efforts?-Results from a study in Wisconsin suggest that making
performance information public stimulates quality improvement, HEALTH
AFFAIRS,vol22,No.2.
|
|
* |
Are Critical Pathways Effective for Reducing postoperative
Length of Stay?, MedicalCare,vol41,No.5,pp637-648.
|
|
* |
Medical Liability and patient safety, Health
Affairs,Vol.22,No.4,2003.
|
|
* |
How can we improve the quality of Health care in Japan?:
Learning from JCQHC Hospital Accreditation, Health Policy
66(2003)29-49.
|
|
* |
Design and analysis of unit cost estimations studies: How many
hospital diagnoses? How many countries?, Health Economics,
12:517-527(2003).
|
|
* |
Financing and planning of public and private not-for-profit
hospitals in the European Union, Health
Policy67(2004)281-291.
|
|
* |
The Cost Effectiveness of Apligraf? Treatment of Diabetic Foot
Ulcers,Phamaco Economics 2003:21(16):1171-1183.
|
|
* |
Analysis of hospital charges for ischemic stroke in
Fukuoka,Japan, Health Policy,66(2003)239-246.
|
|
* |
Nuse Staffing :A structural proxy for hospital
Quality?,Medicalcare,vol42,no1,2004.
|
|
* |
Universal health coverage in Thailand: ideas for reform and
policy struggling,HealthPolicy,68(2004)17-30.
|
|
* |
The nonprofit sector's 亹100 Billion opportunity, Harvard
Business Review May2003.
|
|
* |
Increased spending on Health care: How much can the united
states afford?, Health Affairs, vol22,No.4,2003.
|
|
* |
A Study of Influenza and Influenza-Related Complications among
Children in a large US Health Insurance Plan Database,
Phamacoeconomics;200321(4):273-283.
|
|
* |
Cost Evaluation of Basiliximab Treatment for Renal Transplant
Patients in Japan, Phamacoeconomics:2003;21(11).
|
|
* |
Trends in Medication Use and functioning before retirement
age:Are the linked?, Health Affairs Vol.22,No.4,2003.
|
|
* |
Practical Aspects of Designing and Conducting Phamacoeconomic
Studies in Japan,Phamacoeconomics,2003:21)13):913-925.
|
|
* |
European Healthcare Policies for Controlling Drug Expenditure,
Phamacoeconomics:2003:21(2):89-103.
|
|
* |
Medicare Drug Coverage and Moral Hazard, Health Affairs,
Vol23,No.1,2004.
|
|
* |
Medical student indebtedness and the propensity to enter
academic medicine, Health Economics,12:101-112(2003).
|
|
* |
Health care Policy: Qualitative evidence and health technology
assessment,Health policy,65(2003)217-226.
|
|
* |
Use of deceptive tactics in physician practices: are there
differences between international and US medical graduates?,Health
Policy67(2004)257-264.
|
|
* |
Physician Performance Assessment -Nonquivalence of primary Care
Measures, MedicalCare,vol41,No.9,pp1034-1047.
|
|
* |
A Cost-minimisation study of alternative discharge policies
after hip fracture repair,Health Economics,12:87-100(2003).
|
|
* |
Are the young Becoming more disabled?- Rates of disability
appear to be on the rise among people ages eighteen to fifty-nine, fueled by a
growing obesity epidemic, Health Affair,vol23mNo.1,2004.
|
|
* |
Needs for further improvement: risk adjustment in the German
health insurance system,Health Policy65(2003)21-35.
|
|
* |
Cigarette demand: a meta-analysis of elasticities,Healthcare
Economics,12:821-835(2003).
|
|
* |
Risk Adjusted premium subsides and risk sharing: Key elements
of the competitive sickness fund market in the Netherlands, Health
Policy65(2003)49-62.
|
|
* |
The Prospects for Reform of the Japanese Healthcare System,
Phamacoeconomics2002:20 suppl.:55-66.lOpinions on changes in the Romanian health
care system from people's point of view: a descriptive study,Healt
Policy66(2003)123-134.
|
|
* |
Medicare upcoding and hospital ownership, journal of Health
Economis,23(2004)369-389.
|
|
* |
Towards a new welfare states: the social sustainability
principle and health care strategies, Health policy,
65(2003)201-215.
|
|
* |
The impact of ageing on hospital care and long-term care-the
example of Germany, Health Policy 67(2004)57-74.
|
|
* |
Have DRG-based prospective Payment systems influenced the
number of secondary diagnoses in health care administrative data?, Health
Polivy65(2003)101-107.
|
|
* |
Estimating mean hospital cost as a function of Length of stay
and patient characteristics, Health Care
Economics,12:935-347(2003).
|
|
* |
Clinical Risk Group(CRGs)-A Classification system for
risk-adjusted capitation-Based payment and health care management,Medical
Care,Vol.42,No1,2004.
|
仸Reference: A reading packet
which was used in 2003's program
|
|
* |
echnological development and medical productivity: the
diffusion of angioplasty in New York state, Journal of Health Economics,
22(2003)187-217.
|
|
* |
Selective referrals in a 'hab and spoke'institutional setting
:the case of coronary angioplasty procedures, Health policy,
63(2003)95-107.
|
|
* |
China Cornell - oxford Project http://www.nutrition.cornell.edu/chinaproject/
|
|
* |
Why health equity? , Health Economics
11:659-666(2002).
|
|
* |
Decomposing world health inequality, Journal of Health
Economics, 22(2003)271-293.
|
|
* |
乽宱嵪摑寁偑帵偡擔杮偺奒媺幮夛壔乿乮僄僐僲儈僗僩,2003.2.18乯
|
|
* |
Forecasting the nursing home population, Medical
Care,vol.41,No.1,pp8-20.
|
|
* |
Does insurance coverage for drug therapy Affect Smoking
cessation?, Health Affairs, Vol.21,No.6.
|
|
* |
Health economics evaluation in Japan : a case study of one
aspect of health technology assessment, Health Policy 63 (2003)
197-204.
|
|
* |
The development of health technology assessment, Health Policy,
63(2003)121-132.
|
|
* |
The effect of financial pressure on the quality of care in
hospitals, Journal of Health Economics 22(2003)243-269.
|
|
* |
Competitive spillovers across non-profit and for-profit nursing
homes, Journal of Health Economics 22(2003)1-22.
|
|
* |
The Pfizer foundation's community health ventures program :
Providing model for community health partnerships, Health Affairs,vol.21,
No.6.
|
|
* |
Should we use willingness to pay to elicit community
preferences for health care? New evidence from using a 'marginal'approach,
Journal of Health Economics 21(2002)971-991.
|
|
* |
Development of a model for care-mix adjustment of Pressure
ulcer prevalence rates, Medical Care, Vol.41, No.1,
pp45-55.
|
|
* |
Choice of and overall satisfaction with pharmacies among a
community-dwelling elderly population, Medical Care,
Vol.40,No12,pp1283-1293.
|
|
* |
Enrollee mix, treatment intensity, and cost in competing
indemnity and HMO plans, Journal of Health Economics Vol.22,
No.1,pp23-45.
|
|
* |
No Toyotas in health care: Why medical care has not evolved to
meet patients' needs, Health Affairs, Vol.20, No.6.
|
|
* |
Arm yourself for the coming battle over乣Social Security,
Harvard Business Review, vol.80,No.11.
|
|
* |
Israelis evaluate their health care system before and after the
introduction of the national health insurance law, Health Policy
63(2003)279-287.
|
|
* |
How to identify your enemies before they destroy you, Harvard
Business Review, vol.80,No.11.
|
|
* |
乽恖岥屢娭愡抲姺弍偵懳偡傞僋儕僯僇儖僷僗偺夵椙偲偦偺寢壥乿乮擔杮僋儕僯僇儖僷僗妛夛帍戞係姫俀崋2002擭乯
|
|
* |
Disparity in health Services and outcomes for persons with hip
fracture and lower extremity joint replacement, Medical Care,
Vol.41,No2,pp232-241.
|
|
* |
Prejudice, clinical uncertainty and stereotyping as sources of
health disparities, Journal of Health Economics,
Vol.22,No.1,pp89-116.
|
|
* |
Do interviews agree with medical record and pharmacy data? ,
Medical Care, vol.40,No12,pp1270-1282.
|
|
* |
AIDS is your business, Harvard business review, vol.81.No.2,
pp81-87.
|
|
* |
Managed competition and consumer price sensitivity in social
health insurance, journal of economics 21
(2002)1009-1029.
|
仸Reference : A reading packet
which was used in 2001's and 2002's program
|
|
Introduction: Applying the
Economics Paradigm
|
|
1
|
Folland et al.,Introduction, chapter 1, page
1-
|
|
2
|
Folland et al.,Equity,Efficiency and Need,chapter 19,page
431-432 and 435-442.
|
|
3
|
Aaron,Henry,乬Economic Issues in Health Care" in Aaron, Serious
and Unstable Condition : Financing America's Health Care,Washington,D.C. : The
Brookings Institution 1991,Chapter 2,8-37.
|
|
4
|
Arrow,Keneth,"Uncertainty and the Welfare Economics of Medical
Care",American economic Review, 1963,941-969.(Focus on section ? : special
characteristics of the medical care market.)
|
|
5
|
Fuchs,Victor,"Problems and choices", Who Shall Live?, NY Basic
Books,1975,7-29. Background reading : |
|
6
|
Committee on Ways and Means, "What we Spend on Health Care" in
Medicare and Health Care Chart Book, May 1999.
|
|
7
|
Igleart,John K . "The American Health Care System -
Expenditures"New England Journal of Medicine, 7 January 1999,340(1),70-76.
Folland,Allen Goodman and Miron Stano, The Economics of Health Care, Third
dition. Prentice Hall,2001
|
|
The Production of Health I :
Health Production Functions, Lifestyle Choices
|
|
8
|
Folland et al.,The Production of Health, Chapter 5,page
97-
|
|
9
|
Folland et al.,The Health Economics of Bads, Chapter
25,page571- (see pages 36-37 for a review of
elasticities)
|
|
10
|
Manning,Willard G.,Emmett B.Keeler,Joseph P.Newhouse,Elizabeth
M.Sloss and Jeffrey Wasserman, "The Taxes of Sin : Do Smokers and Drinkers Pay
Their Way?"Journal of the American Medical Association
|
|
The production of health?: The
Cost and Effectiveness of Health Care
|
|
11
|
Folland et al.,Cost-Benefit Analysis and Other Tools of
Economics Evalution,Chapter 4,page74-
|
|
12
|
Cutler,David,"Public Policy for Health Care",in Alan
Auerbach,ed.,Fiscal Policy : Lessons from Economic Research, Cambridge,MA : MIT
Press,1997,Chapter 5, 159-198. Also,NBER working paper
no.w5591.
|
|
13
|
Glied,Sherry,"Can We Afford More Health Care?"in Glied,Chronic
Condition : Why Health Reform Fils,Cambridge and London : Harvard University
Press,1997,Chapter 4,pp .86-121.
|
|
14
|
Leutwyler ,Kristin,"The Price of Prevention"Scientific American
1995,124-129.
|
|
15
|
Weisbrod,Burton,"The Health Care Quadrilemma : An Easy on
Technological Change,Insurance,Quality of Care,and Cost Containment" Journal of
Economic Literature,June 1991,29,523-552.Background reading
:
|
|
16
|
New York Times,"The Medical Industry : Hope for Sale",3 October
1999.
|
|
Government Intervention in
Health Care Markets
|
|
17
|
Folland et al.,Government Intervention in Health Care
Markets,Chapter 20,pages 445-459.
|
|
18
|
Folland et al.,Social Insurance,Chapter 22,page
502-
|
|
19
|
Fuchs,Victor,"National Health Insurance Revisited"in Fuchs,The
Future of Health Policy,Cambridge, MA : Harvard University Press,1993, Chapter
14,204-217.
|
|
20
|
Frank,Richard and David Salkever, "Nonprofit Organizations in
the health sector",Journal of Economic Perspectives,1994,8(4),129-144.
Background reading :
|
|
21
|
Iglehart,John K."The American Health Care System : Medicare",
New England Journal of Medicine,28 January
1999,340(4),317-332.
|
|
Comparative Health Care
Systems
|
|
22
|
Iglehart,John K."The American Health Care System :
Medicaid",New England Journal of Medicine,4 February
1999,340(5),403-408.
|
|
23
|
Folland et al., Comparative Health Care Systems,Chapter 23,page
528-
|
|
24
|
Anderson, Gerard,Jeremy Hurst,Peter Sotir Hussey and Melissa
Jee-Hughes, "Health Spending and Outsomes : Trends in OECD
Countries,1960-1998",Health Affairs,2000,19(3), 150-157.
|
|
25
|
Fuchs,Victor and James Hahn,"How Does Canada Do It? A
Comparison of Expenditure for Physicians' Services in the United States and
Canada" New England Journal of Medicine,27 September 1990,
884-890.
|
|
26
|
The World Health Organization, World Health Report 2000.
Especially chapter 5, "Who Pays for Health Systems".
|
|
27
|
U.S. Social Security Administration,"Social Security Programs
Throughout the World 1999" This is description of social security
programs(broadly defined) from over 170 countries. Read pages xv-xix of the
guide, and any subsequent chapters you find of
interest.
|
|
The Demand for Health
Care
|
|
28
|
Follamd et al., Consumer Choice and Demand,Chapter 8,page
164-
|
|
29
|
Manning,Willard Joseph P . Newhouse, Naihua Duan, Emmett B .
Keeler, Arleen Liebowits and M.Susan Marquis,"Health Insurance and the Demand
for Medical Care : Evidence from a Randomized
|
|
The Economics of Health
Insurance
|
|
30
|
Folland et al., Demand and Supply of Health Insurance,Chapter
7,pages 141-144 and 150-161.
|
|
31
|
Folland et al., Asymmetric Information and Agency, Chapter
9,pages 187-195.
|
|
Paying for Health Insurance and
Health Care
|
|
32
|
Folland et al., The Organization of Health Insurance Markets,
Chapter 11,pages 230-244.
|
|
33
|
Folland et al., Health System Reform, Chapter 24,pages
558-563.
|
|
34
|
Krueger,Alan B .and Uwe E . Reinhardt,"The Economics of
Employer Versus Individual Medicate",Health Affairs 1994,spring (?),
34-53.
|
|
35
|
Pauly,Mark,Health Benefits at Work : An Econimics of Political
Analysis of Employment-Based Health Insurance,Ann Arbor : University of Michigan
Press,1997, Chapter 1,1-13.
|
|
36
|
Summers,Lawrence,"Some Simple Economics of Mandated
Benefits"American Economic Review,May 1989, 79(2), 177-183. http://www.jstor.org Background
reading :
|
|
37
|
Holahan, John and Johnny Kim "Why Does The Number Of Uninsured
Americans Continue To Grow?" Health
Affairs,2000,19(4),188-196
|
|
Payment Systems and Cost
Control
|
|
38
|
Folland et al., Imperfect Information : Supplier Induced Demand
and Small Area Variations, Chapter 10,page 204-
|
|
39
|
Folland et al., Managed Care, Chapter 12,pages
248-261.
|
|
40
|
Folland et al., Government Regulation- Principal Regulatory
Mechanism, Chapter 21,pages 470-789.
|
|
41
|
Committee on Ways and Means,1998 Green Book."Section2 :
Medicare"101-153,"Appendix D : Medicare Reimbursement to Hospitals" 1117-1130
and "Appendix E : Medicare Reimbursement to Physicians"1195-1203 http://www.access.gpo.gov/congress/wm001.html Select 乬1998
Green Book" and enter search term"Medicare".
|
|
42
|
Ellis,R.and T. McGuire, "Supply-side and Demand-side Cost
Sharing in Health Care"Journal of Economic Perspectives,Fall 1993,7(4), 135-151.
Background reading : http://www.jstor.org
|
|
43
|
The New York Times, "Health Care - Recent Coverage",2000.
Especially,"Estimate of Ouster by HMO's IS Raised "by Robert Pear,25 July 2000.
http://www.nytimes.com/library/politics/index-healthcare.html
Especially, "Estimate of Ousters by HMO's Is Raised"by Robert Pear,25 July
2000.
|
|
Physicians and Other Health
Care Sector Workers
|
|
44
|
Folland et al., Labor Markets and Professional Traning, Chapter
15,pages 323-
|
|
45
|
Folland et al., The Traning and practice of Physicians ,Chapter
16,page 347-
|
|
46
|
Gaynor,Martin,"Issues in the Indusrial Organization of the
Market for Phvsician Services" ,Journal of Economics and, Management
Strategy1994,3, 211-255.
|
|
47
|
Kessler,Daniel and Mark McClellan,"Do Doctors Practice
Defensive Medicine?"Quarterly Journal Of Economics,May 1996,111(2),
353-390.
|
|
48
|
Simon,Carol J., William D .White,Sandy Gamliel, and Philip R.
Kletke,"The Provision of Primary Care : Does Managed Care Make A
Difference?"Health Affairs, November/December 1997,
89-98.
|
|
Hospitals and Other
Institutions
|
|
49
|
Folland et al., Hospitals and Long-Term Care, Chapter 18,page
399-
|
|
50
|
Connor,Robert A., Roger D.Feldman, Bryan E .Dowd, and Tiffany A
. Radcliff,"Which Types of Hospital Mergers Save Consumers Money?" Health
Affairs, 1997,16(6),62-74
|
|
51
|
Dranove,David and William D. White, "Recent Theory and Evidence
on Competition in Hospital Markets" Journal of Economics and Management
Strategy, Spring 1994, 3, 169-209.
|
|
52
|
Gaynor, M .and D . Haas-Wilson, "Change , Consolidation, and
Competition in Health Care Markets", Journal of Economic Perspectives, Winter
1999, 13(1), 141-164.
|
|
53
|
Reinhardt,Uwe(1996), "Spending more through cost control : Our
obsessive quest to gut the hospital", Health Affairs ,1996, 15(2),
145-154.
|
|
54
|
Sloan,Frank A., "Commercialism in Nonprofit Hospitals"Journal
of Policy analysis and Management, 1998, 17(2), 234-252. http://www.interscience.wiley.com/jpages/0276-8739/
|
|
Evaluating Managed
Care
|
|
55
|
Folland et al.,Managed Care , Chapter 12, pages
261-278.
|
|
56
|
Cutler,David and Louise Sheiner , "Managed care and the growth
of medical expendintures" in Alan M .Garber , ed .,Frontiers in Health Policy
Research , Volume 1, Cambridge , MA : MIT Press,1998. Also, NBER working paper
no. w6140. http://papers.nber.org/papers/w6140/
|
|
57
|
Miller, Robert and Harold Luft, "Managed Care Plane Performance
Since 1980 : A Literature Analysis," Journal of the American Medical
Association,18May 1994, 271(19),1512-1519.
|
|
58
|
Miller, Robert H. and Harold S. Luft, "Does Managed Care Lead
to Better or Worse Quality of Care ?" Health Affairs, September/October
1997,7-25.
|
|
59
|
Siu,Albert L., Arleen Leibowitz, Robert H. Brook,Nancy
S.Goldman, Nicole Lurie and Joseph P.Newhouse, "Use of the Hospital in a
Randomized Trial of Prepaid Care" Journal of the American Medical Association
,1998,259,1343-1346.
|
|
Pharmaceuticals and Final
Examination
|
|
60
|
Folland et al., The Pharmaceutical Industry, Chapter 26,page
583-
|
|
61
|
Patricia Danzon, "Marking sense of drug prices", Regulation
2000,23(1),56-63.
|
|
62
|
Sorensen, Alan T., "Equilibrium Price Dispersion in Retail
Markets for Prescription Drugs", Journal of Political
Economy,2000,108(4),833-850. http://www.journals.uchicago.edu/ The New York Times,
"Medicine Merchants",2000.
|
|
63
|
http://www.nytimes.com/library/national/science/health/pharmaceuticals-health.html
Especially,"How
Companies Stall Generics and Keep Themselves Healthy "and" In a Drug's Journey
to Market, Discovery Is Just the First of Many Steps",by Shery 1 Gay Stolberg
and Jeff Gerth ,23 July 2000.
|
|
|
|
|
|
|
|
| Copyright(c)2010 Koichi KAWABUCHI Research Laboratory All Rights Reserved. |
|
|
